Vanda Pharmaceuticals Inc. (VNDA)
USD 4.57
(2.93%)
USD 4.57
(2.93%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 177.84 Million USD | -23.62% |
| 2022 | 230.1 Million USD | -5.33% |
| 2021 | 243.05 Million USD | 8.12% |
| 2020 | 224.8 Million USD | 10.9% |
| 2019 | 202.7 Million USD | 17.43% |
| 2018 | 172.61 Million USD | 17.23% |
| 2017 | 147.23 Million USD | 21.38% |
| 2016 | 121.3 Million USD | 40.3% |
| 2015 | 86.46 Million USD | 78.0% |
| 2014 | 48.57 Million USD | 43.37% |
| 2013 | 33.87 Million USD | 3.93% |
| 2012 | 32.59 Million USD | 4.25% |
| 2011 | 31.27 Million USD | 1.41% |
| 2010 | 30.83 Million USD | 1768.59% |
| 2009 | 1.65 Million USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | -100.0% |
| 2004 | 33.98 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 42 Million USD | 0.46% |
| 2024 Q2 | 45.98 Million USD | 9.49% |
| 2023 Q2 | 42.55 Million USD | -26.28% |
| 2023 Q1 | 57.72 Million USD | -0.89% |
| 2023 Q3 | 35.75 Million USD | -15.99% |
| 2023 Q4 | 41.81 Million USD | 16.95% |
| 2023 FY | 175.75 Million USD | -23.62% |
| 2022 Q1 | 54.52 Million USD | -11.74% |
| 2022 Q3 | 58.99 Million USD | 1.14% |
| 2022 Q2 | 58.33 Million USD | 6.98% |
| 2022 Q4 | 58.24 Million USD | -1.28% |
| 2022 FY | 230.1 Million USD | -5.33% |
| 2021 Q2 | 61.33 Million USD | 8.29% |
| 2021 Q1 | 56.63 Million USD | -7.51% |
| 2021 Q3 | 63.29 Million USD | 3.2% |
| 2021 Q4 | 61.78 Million USD | -2.39% |
| 2021 FY | 243.05 Million USD | 8.12% |
| 2020 Q2 | 56.36 Million USD | 6.76% |
| 2020 Q3 | 54.41 Million USD | -3.46% |
| 2020 Q4 | 61.24 Million USD | 12.55% |
| 2020 FY | 224.8 Million USD | 10.9% |
| 2020 Q1 | 52.79 Million USD | -3.5% |
| 2019 Q3 | 52.7 Million USD | 0.02% |
| 2019 Q1 | 42.6 Million USD | -10.08% |
| 2019 FY | 202.7 Million USD | 17.43% |
| 2019 Q4 | 54.7 Million USD | 3.8% |
| 2019 Q2 | 52.69 Million USD | 23.69% |
| 2018 FY | 172.61 Million USD | 17.23% |
| 2018 Q4 | 47.37 Million USD | 7.5% |
| 2018 Q2 | 42.13 Million USD | 7.96% |
| 2018 Q3 | 44.06 Million USD | 4.58% |
| 2018 Q1 | 39.03 Million USD | -1.15% |
| 2017 Q3 | 36.81 Million USD | -1.91% |
| 2017 Q2 | 37.52 Million USD | 12.32% |
| 2017 Q1 | 33.41 Million USD | 1.33% |
| 2017 FY | 147.23 Million USD | 21.38% |
| 2017 Q4 | 39.48 Million USD | 7.26% |
| 2016 Q3 | 31.49 Million USD | 6.63% |
| 2016 FY | 121.3 Million USD | 40.3% |
| 2016 Q1 | 27.3 Million USD | 6.34% |
| 2016 Q2 | 29.53 Million USD | 8.16% |
| 2016 Q4 | 32.97 Million USD | 4.7% |
| 2015 FY | 86.46 Million USD | 78.0% |
| 2015 Q4 | 25.67 Million USD | 17.61% |
| 2015 Q3 | 21.83 Million USD | 0.08% |
| 2015 Q2 | 21.81 Million USD | 27.32% |
| 2015 Q1 | 17.13 Million USD | 16.66% |
| 2014 Q2 | 10.66 Million USD | 16.64% |
| 2014 FY | 48.57 Million USD | 43.37% |
| 2014 Q3 | 14.07 Million USD | 32.02% |
| 2014 Q1 | 9.14 Million USD | 4.1% |
| 2014 Q4 | 14.68 Million USD | 4.33% |
| 2013 Q2 | 8.31 Million USD | 3.11% |
| 2013 Q1 | 8.06 Million USD | 3.56% |
| 2013 FY | 33.87 Million USD | 3.93% |
| 2013 Q3 | 8.7 Million USD | 4.69% |
| 2013 Q4 | 8.78 Million USD | 0.85% |
| 2012 Q2 | 8.37 Million USD | 2.91% |
| 2012 Q3 | 8.28 Million USD | -1.07% |
| 2012 FY | 32.59 Million USD | 4.25% |
| 2012 Q4 | 7.79 Million USD | -6.0% |
| 2012 Q1 | 8.14 Million USD | -2.74% |
| 2011 Q3 | 7.96 Million USD | 7.25% |
| 2011 Q1 | 7.5 Million USD | -15.43% |
| 2011 Q2 | 7.43 Million USD | -0.95% |
| 2011 Q4 | 8.37 Million USD | 5.03% |
| 2011 FY | 31.27 Million USD | 1.41% |
| 2010 Q2 | 6.4 Million USD | -40.04% |
| 2010 Q1 | 10.67 Million USD | 373.21% |
| 2010 Q4 | 8.86 Million USD | 29.12% |
| 2010 FY | 30.83 Million USD | 1768.59% |
| 2010 Q3 | 6.86 Million USD | 7.31% |
| 2009 Q2 | -229.35 Thousand USD | 0.0% |
| 2009 Q4 | 2.25 Million USD | 698.81% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q3 | -376.79 Thousand USD | -64.29% |
| 2009 FY | 1.65 Million USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q2 | - USD | -100.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q1 | 3.46 Million USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 FY | - USD | -100.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2004 FY | 33.98 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Absci Corporation | -41.84 Million USD | 524.966% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -87.752% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 88.283% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 350600.591% |
| Apollomics, Inc. | 127 Thousand USD | -139934.646% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 168393.352% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 773334.783% |
| Bicycle Therapeutics plc | -129.52 Million USD | 237.31% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -22075.062% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -148103.333% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -786.914% |
| Chimerix, Inc. | 324 Thousand USD | -54790.123% |
| CRISPR Therapeutics AG | 240.95 Million USD | 26.192% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -257.081% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -329.72% |
| Fortress Biotech, Inc. | 57.85 Million USD | -207.407% |
| Fortress Biotech, Inc. | 57.85 Million USD | -207.407% |
| Gritstone bio, Inc. | -6.26 Million USD | 2940.958% |
| Allakos Inc. | -6.14 Million USD | 2996.01% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 18683.49% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -1102.136% |
| Cytokinetics, Incorporated | -322.59 Million USD | 155.13% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 101725.143% |
| Innoviva, Inc. | 261.06 Million USD | 31.878% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 1559041.094% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 5108.279% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 1769515.979% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 20286.606% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 44672.431% |
| ImmuCell Corporation | 4.39 Million USD | -3945.326% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 267.583% |
| Incyte Corporation | 3.44 Billion USD | 94.831% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 6757.014% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -91238.825% |
| Mustang Bio, Inc. | -2.22 Million USD | 8092.989% |
| MiMedx Group, Inc. | 266.84 Million USD | 33.353% |
| MEI Pharma, Inc. | 49.32 Million USD | -260.541% |
| MacroGenics, Inc. | 50.52 Million USD | -251.978% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Mereo BioPharma Group plc | 7.42 Million USD | -2294.883% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 2602.851% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -512.094% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -26.848% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 574123.627% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 183444.33% |
| NextCure, Inc. | -3.68 Million USD | 4927.47% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -6809.246% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -833.907% |
| Onconetix, Inc. | -1.12 Million USD | 15877.992% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 713.933% |
| Opthea Limited | 21.72 Thousand USD | -818702.947% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 14860.308% |
| Psyence Biomedical Ltd. | -240.00 USD | 74101766.667% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 310332.704% |
| Precigen, Inc. | 106 Thousand USD | -167677.358% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -17525.768% |
| Prime Medicine, Inc. | -147.9 Million USD | 220.242% |
| PureTech Health plc | -1.6 Million USD | 11194.448% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 2605.551% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 98.426% |
| Replimune Group, Inc. | -2.65 Million USD | 6798.456% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 710084.431% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -62.012% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 34516.135% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 144.498% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | -344.61% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 492.375% |
| Solid Biosciences Inc. | -76.56 Million USD | 332.285% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 1482133.333% |
| SciSparc Ltd. | 2.19 Million USD | -7998.543% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 766.232% |
| TG Therapeutics, Inc. | 219.1 Million USD | 18.833% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -5775.256% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 10385.946% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -32.93% |
| UroGen Pharma Ltd. | 73.35 Million USD | -142.453% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -3962.22% |
| XOMA Corporation | 3.86 Million USD | -4506.164% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 12903.744% |
| AbCellera Biologics Inc. | 38.02 Million USD | -367.703% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 3556980.0% |
| Cassava Sciences, Inc. | -89.42 Million USD | 298.879% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 670.604% |
| Precision BioSciences, Inc. | 40.47 Million USD | -339.425% |
| Dyadic International, Inc. | 922.95 Thousand USD | -19168.937% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 121082.313% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -744.423% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -41844.34% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 2147.243% |
| IGM Biosciences, Inc. | -211.66 Million USD | 184.023% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 9010.02% |
| Acelyrin, Inc. | -115 Thousand USD | 154746.957% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -7203.655% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -48.509% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 1431.382% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -14.893% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 281.073% |
| Senti Biosciences, Inc. | -2.68 Million USD | 6728.55% |
| Mesoblast Limited | -9.81 Million USD | 1911.961% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 260.961% |
| ChromaDex Corporation | 50.78 Million USD | -250.224% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -47.62% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 7.02 Million USD | -2430.867% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -31.474% |
| Novavax, Inc. | 639.93 Million USD | 72.209% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 281.172% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 509.185% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -136703.077% |
| Celcuity Inc. | -142.77 Thousand USD | 124665.041% |
| ContextLogic Inc. | 59 Million USD | -201.431% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -34432.816% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -972.836% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 94.767% |
| Amarin Corporation plc | 165.54 Million USD | -7.432% |
| AnaptysBio, Inc. | 14.78 Million USD | -1103.193% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 31465.785% |
| Aptorum Group Limited | -1.11 Million USD | 16054.599% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -627.349% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 26.125% |
| Ardelyx, Inc. | 106.66 Million USD | -66.738% |
| Celularity Inc. | 6.75 Million USD | -2532.776% |
| Omeros Corporation | -69.77 Million USD | 354.868% |
| Humacyte, Inc. | -76.55 Million USD | 332.324% |
| Immunocore Holdings plc | 248.39 Million USD | 28.402% |
| IO Biotech, Inc. | -756 Thousand USD | 23624.339% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 12571.529% |
| Summit Therapeutics Inc. | -2.05 Million USD | 8775.317% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 3806.628% |
| Pulmatrix, Inc. | -8.22 Million USD | 2263.552% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 144.595% |
| Evogene Ltd. | 1.39 Million USD | -12612.223% |
| CorMedix Inc. | -205.56 Thousand USD | 86615.99% |
| BioLineRx Ltd. | 1.1 Million USD | -15950.903% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -35755.645% |
| Sagimet Biosciences Inc. | 2 Million USD | -8792.2% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 79.613% |
| scPharmaceuticals Inc. | 9.78 Million USD | -1718.074% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 357.76% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 62.629% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 1559041.094% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 613355.172% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 94197.354% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -4290.126% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 33975.048% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 402571.259% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 1802.678% |
| Daré Bioscience, Inc. | 2.76 Million USD | -6321.469% |
| bluebird bio, Inc. | -4.03 Million USD | 4513.002% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 90.661% |
| DBV Technologies S.A. | 15.72 Million USD | -1030.748% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 198.035% |
| Galecto, Inc. | -830 Thousand USD | 21526.988% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 31246.06% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 552.035% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -29102.627% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 124205.205% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -225.608% |
| ADMA Biologics, Inc. | 88.21 Million USD | -101.596% |
| Clene Inc. | 533 Thousand USD | -33266.604% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -8845.875% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 37576.741% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 1710138.462% |
| Soligenix, Inc. | 97.31 Thousand USD | -182658.373% |
| Century Therapeutics, Inc. | -10.8 Million USD | 1745.333% |
| Kura Oncology, Inc. | -849 Thousand USD | 21047.468% |
| Surrozen, Inc. | -27.23 Million USD | 753.118% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 365.027% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -79.57% |
| Autolus Therapeutics plc | -4.86 Million USD | 3754.078% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 105959.524% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 329.186% |
| GRI Bio, Inc. | 10.84 Million USD | -1540.476% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -6901.771% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 479.692% |
| INmune Bio, Inc. | 155 Thousand USD | -114638.065% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -187.128% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 11906.749% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 27525.847% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 2349426.288% |
| Jaguar Health, Inc. | 7.72 Million USD | -2202.486% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 607615.201% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -44139.801% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -2159.484% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 56919.169% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -88.272% |
| Verastem, Inc. | -62 Thousand USD | 286945.161% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 68239.464% |
| Histogen Inc. | 3.76 Million USD | -4618.599% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -30766.102% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 73.874% |
| Surrozen, Inc. | -27.23 Million USD | 753.118% |
| Organovo Holdings, Inc. | -5.38 Million USD | 3400.13% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 8982120.202% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -2831.612% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 265020.826% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -121878.052% |
| Kronos Bio, Inc. | 1.37 Million USD | -12862.391% |
| Turnstone Biologics Corp. | 16.5 Million USD | -977.451% |
| Synaptogenix, Inc. | -6347.00 USD | 2802116.701% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 348813.725% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -510.539% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -10.212% |
| Exelixis, Inc. | 1.75 Billion USD | 89.882% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 258.561% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 47.396% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 16150.903% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 150190.724% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -2330.227% |
| Insmed Incorporated | 239.63 Million USD | 25.785% |
| MediWound Ltd. | 3.57 Million USD | -4870.486% |
| OmniAb, Inc. | 14.66 Million USD | -1112.545% |
| Alector, Inc. | -95.05 Million USD | 287.1% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -41.572% |
| Zai Lab Limited | 170.9 Million USD | -4.061% |
| AlloVir, Inc. | -398 Thousand USD | 44784.422% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -117.209% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 17332.946% |
| Aura Biosciences, Inc. | -1.29 Million USD | 13833.127% |
| Immunic, Inc. | -111 Thousand USD | 160319.82% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -1021.761% |
| Veracyte, Inc. | 248.14 Million USD | 28.331% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 102.545% |
| FibroGen, Inc. | 128.9 Million USD | -37.966% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 43.303% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 31532724.113% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 1624.349% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -45618.252% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 49.952% |
| Fortrea Holdings Inc. | 424 Million USD | 58.056% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 306.395% |
| XBiotech Inc. | -1.74 Million USD | 10297.477% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 16150.903% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 26883.735% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 482.699% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 335.449% |
| Agenus Inc. | 139.61 Million USD | -27.382% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -142.284% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -958.406% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 54.286% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 458.217% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 45.572% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 1670.527% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 283.439% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -3293307.407% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 266225.967% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 101816.397% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 47651.872% |
| Ainos, Inc. | -253.73 Thousand USD | 70191.001% |
| Pluri Inc. | 322 Thousand USD | -55131.056% |
| Prothena Corporation plc | -129.2 Million USD | 237.649% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -252.698% |
| Rallybio Corporation | -150 Thousand USD | 118662.667% |
| Kodiak Sciences Inc. | -25.94 Million USD | 785.413% |
| Cue Biopharma, Inc. | -32.6 Million USD | 645.417% |
| MeiraGTx Holdings plc | 287 Thousand USD | -61866.551% |
| Annexon, Inc. | -3.26 Million USD | 5543.649% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 526.106% |
| Moderna, Inc. | 2.15 Billion USD | 91.747% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 1272.417% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -185.089% |
| Blueprint Medicines Corporation | 236.58 Million USD | 24.828% |
| Immix Biopharma, Inc. | -5468.00 USD | 3252550.622% |
| CalciMedica, Inc. | -58 Thousand USD | 306727.586% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 2958.309% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 6353.305% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -70.841% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 676.2% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 15300.342% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -6307.442% |
| Nutriband Inc. | 862.1 Thousand USD | -20529.042% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 52253.666% |
| Vor Biopharma Inc. | -3.49 Million USD | 5192.898% |
| Roivant Sciences Ltd. | 109.23 Million USD | -62.809% |
| Alkermes plc | 1.37 Billion USD | 87.063% |
| ProKidney Corp. | -3.16 Million USD | 5711.991% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 505.001% |
| Arcellx, Inc. | 108.27 Million USD | -64.246% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -2493.612% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 326.06% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 539021.212% |
| Atai Life Sciences N.V. | -5000.00 USD | 3556980.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 146042.442% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 185354.167% |
| MediciNova, Inc. | 979.7 Thousand USD | -18052.811% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 310.918% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 188185.241% |
| GeoVax Labs, Inc. | -20.72 Million USD | 958.289% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 27.273% |
| Biomea Fusion, Inc. | -4.2 Million USD | 4333.373% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 57469.032% |
| Geron Corporation | -123.5 Million USD | 244.0% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 3556980.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 332.862% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 7326.493% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 16.792% |
| Royalty Pharma plc | 1.79 Billion USD | 90.086% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 18999.469% |
| Imunon, Inc. | -720 Thousand USD | 24800.384% |
| BioAtla, Inc. | -103.73 Million USD | 271.447% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 173.241% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 57284.566% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 259.624% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 18836.712% |
| 89bio, Inc. | -273 Thousand USD | 65244.322% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 353.755% |
| aTyr Pharma, Inc. | -2.38 Million USD | 7547.404% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -1327.319% |
| Viridian Therapeutics, Inc. | -1 Million USD | 17743.254% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -1368030669.231% |
| Akari Therapeutics, Plc | -4000.00 USD | 4446200.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 72.076% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -15793.119% |
| Liquidia Corporation | 14.6 Million USD | -1118.11% |
| Entera Bio Ltd. | -56 Thousand USD | 317678.571% |
| GH Research PLC | -315 Thousand USD | 56558.413% |
| Vericel Corporation | 135.57 Million USD | -31.177% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 420.099% |
| Xencor, Inc. | -85.26 Million USD | 308.59% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 80580.774% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 27525.847% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 17862.446% |
| Vaxcyte, Inc. | -75 Million USD | 337.125% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 206.168% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -91238.825% |
| Portage Biotech Inc. | -54 Thousand USD | 329440.741% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 188185.241% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 47273.475% |
| OncoCyte Corporation | 413 Thousand USD | -42961.501% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 3956584.983% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 80110009.91% |
| Purple Biotech Ltd. | -196 Thousand USD | 90836.735% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 46778.215% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 908.86% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -161.052% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -1883.095% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 140134.646% |
| United Therapeutics Corporation | 2.07 Billion USD | 91.409% |
| HilleVax, Inc. | -2.15 Million USD | 8348.794% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -268287.058% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 4611.462% |
| Pharming Group N.V. | 220.1 Million USD | 19.2% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 1185410.584% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 26723.353% |
| Pyxis Oncology, Inc. | -2 Million USD | 8992.2% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 2369407.342% |
| Savara Inc. | -44.26 Million USD | 501.798% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 216982.927% |
| Curis, Inc. | 9.81 Million USD | -1712.7% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 142616.909% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 78101.754% |
| BeiGene, Ltd. | 2.07 Billion USD | 91.445% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -213.724% |
| Erasca, Inc. | -3.73 Million USD | 4865.38% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 630350.195% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 630350.195% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 19536.503% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -2121.384% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 33279.851% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 260.035% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 5056.633% |
| Adicet Bio, Inc. | -6.09 Million USD | 3016.432% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 50.876% |
| Aditxt, Inc. | -111.66 Thousand USD | 159372.792% |
| Adagene Inc. | 18.11 Million USD | -881.94% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -36343.443% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -12.676% |
| Compugen Ltd. | 31.45 Million USD | -465.392% |
| Generation Bio Co. | -73.91 Million USD | 340.619% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 40796.568% |
| Invivyd, Inc. | -2.02 Million USD | 8869.428% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 159.116% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 172032.945% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -84.547% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -80.942% |
| Instil Bio, Inc. | -4.75 Million USD | 3839.361% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -637.661% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -15574.875% |
| GeoVax Labs, Inc. | -20.72 Million USD | 958.289% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 91623.086% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 21373.206% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -113.204% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -243148.714% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -234.532% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 202.688% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 50480.737% |
| Cingulate Inc. | -582.91 Thousand USD | 30609.265% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 573790.323% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 1002.807% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 18100.405% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 315750.847% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 431.39% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 61005.479% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 33846.49% |
| ImmunityBio, Inc. | -17.89 Million USD | 1094.097% |
| Korro Bio, Inc. | -3.63 Million USD | 4999.284% |
| Kineta, Inc. | 5.43 Million USD | -3173.403% |
| BioVie Inc. | -229.37 Thousand USD | 77633.493% |
| Codexis, Inc. | 57.33 Million USD | -210.189% |
| Celularity Inc. | 6.75 Million USD | -2532.776% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 149548.739% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -4331.697% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -351439.83% |
| Cibus, Inc. | 1.42 Million USD | -12406.61% |
| IN8bio, Inc. | -2.5 Million USD | 7210.916% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 8800.783% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -27688.125% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 77.156% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -2.827% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Elevation Oncology, Inc. | -39 Thousand USD | 456110.256% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 9460.211% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 649.427% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -124.539% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 940.79% |
| Moolec Science SA | -143.3 Thousand USD | 124201.741% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 520.256% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -5310.526% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 353.737% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 9509.735% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 4923798.782% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -76758.651% |
| Humacyte, Inc. | -76.55 Million USD | 332.324% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 14248.29% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 21072.17% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 144688.618% |
| Notable Labs, Ltd. | 113 Thousand USD | -157284.071% |
| Immunovant, Inc. | -231 Thousand USD | 77088.745% |
| Quantum-Si incorporated | 488 Thousand USD | -36343.443% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 592913.333% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -9451.235% |
| Acasti Pharma Inc. | -11 Thousand USD | 1616863.636% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 87015.554% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 9182.942% |
| PepGen Inc. | -1.18 Million USD | 15120.608% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 876.713% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 215451.828% |
| Immuneering Corporation | -764.13 Thousand USD | 23373.807% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | -399 Thousand USD | 44672.431% |
| XOMA Corporation | 3.86 Million USD | -4506.164% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 987.622% |
| Bionomics Limited | -434.44 Thousand USD | 41035.53% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 16659.032% |
| uniQure N.V. | 2.21 Million USD | -7929.074% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 293.164% |
| Forte Biosciences, Inc. | -9000.00 USD | 1976144.444% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 21398.683% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 40796.568% |
| Altimmune, Inc. | -65.37 Million USD | 372.045% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 7488.617% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 16659.032% |
| Peak Bio, Inc. | 367.76 Thousand USD | -48257.529% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -625.42% |
| Benitec Biopharma Inc. | 108 Thousand USD | -164570.37% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 228105.128% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 14883.375% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 9860.922% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 14883.375% |
| argenx SE | 1.1 Billion USD | 83.956% |
| Immunome, Inc. | -8.9 Million USD | 2096.677% |
| Verona Pharma plc | -679.62 Thousand USD | 26267.999% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 101725.143% |
| Shattuck Labs, Inc. | -2.38 Million USD | 7556.771% |
| CervoMed Inc. | -1.29 Million USD | 13847.703% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 3822.922% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -7097.248% |
| Moolec Science SA | -143.3 Thousand USD | 124201.741% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 43686.011% |
| Design Therapeutics, Inc. | -537 Thousand USD | 33218.063% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 41749.649% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -8187.232% |
| Achilles Therapeutics plc | -4.73 Million USD | 3858.909% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 490.454% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -413490.698% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 21735.523% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 1351703.587% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 539021.212% |
| Beam Therapeutics Inc. | -59.67 Million USD | 398.036% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -27.638% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -725.454% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 59980.135% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 4516.249% |
| NeurAxis, Inc. | 2.15 Million USD | -8146.101% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 1959.126% |
| Lumos Pharma, Inc. | 2 Million USD | -8761.186% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -461.753% |
| Palisade Bio, Inc. | 246 Thousand USD | -72194.309% |
| Nutriband Inc. | 862.1 Thousand USD | -20529.042% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -1163.097% |
| Neurogene Inc. | -3.26 Million USD | 5551.993% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 323452.727% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 4917.01% |
| Athira Pharma, Inc. | -969 Thousand USD | 18453.354% |
| HCW Biologics Inc. | -574.82 Thousand USD | 31038.861% |
| XOMA Corporation | 3.86 Million USD | -4506.164% |
| Nektar Therapeutics | 53.47 Million USD | -232.555% |
| Arvinas, Inc. | 71.8 Million USD | -147.694% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 313.086% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 383.304% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 55331.056% |
| Rezolute, Inc. | -36 Thousand USD | 494111.111% |
| Clene Inc. | 533 Thousand USD | -33266.604% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 13850878.816% |
| BeyondSpring Inc. | 1.75 Million USD | -10056.71% |
| Synlogic, Inc. | -1.92 Million USD | 9343.451% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 480759.459% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 2908.654% |
| Peak Bio, Inc. | 367.76 Thousand USD | -48257.529% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 1037.847% |
| Krystal Biotech, Inc. | 47.6 Million USD | -273.583% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -26.049% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -3439.184% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 6968.635% |
| MannKind Corporation | 136.19 Million USD | -30.584% |
| Ikena Oncology, Inc. | -50.49 Million USD | 452.222% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -63.439% |
| Gossamer Bio, Inc. | -4.38 Million USD | 4155.735% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 70673.016% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 3556980.0% |
| Legend Biotech Corporation | 140.92 Million USD | -26.194% |
| Mural Oncology plc | -2.56 Million USD | 7028.087% |
| Disc Medicine, Inc. | -100 Thousand USD | 177944.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -756.914% |
| REGENXBIO Inc. | 53.02 Million USD | -235.371% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 3419.872% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 92546.524% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 10368.129% |
| Vaxart, Inc. | -60.76 Million USD | 392.685% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 67777.905% |
| Cellectis S.A. | 18 Thousand USD | -987922.222% |
| Longeveron Inc. | 221 Thousand USD | -80372.398% |
| Repare Therapeutics Inc. | -80.07 Million USD | 322.111% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 83.729% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 13843.74% |
| Revolution Medicines, Inc. | -399.66 Million USD | 144.498% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 508225.714% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -362846.939% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 97.934% |
| Denali Therapeutics Inc. | -93.34 Million USD | 290.523% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 710084.431% |
| Veru Inc. | 7.56 Million USD | -2250.591% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 117877.483% |
| Cingulate Inc. | -582.91 Thousand USD | 30609.265% |
| Passage Bio, Inc. | -3.72 Million USD | 4879.468% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 1476719.063% |
| Exicure, Inc. | -1.42 Million USD | 12597.822% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 46534.465% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -6479.504% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 34789.423% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 118974.117% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 400.382% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -45384.399% |
| OmniAb, Inc. | 14.66 Million USD | -1112.545% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -789.531% |
| Lipocine Inc. | -2.85 Million USD | 6338.35% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 9749.702% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 3217.336% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 11906.749% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -136.13% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 273706.154% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -110.976% |
| Ocugen, Inc. | -33.53 Million USD | 630.292% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 5724.415% |
| Q32 Bio Inc. | 578 Thousand USD | -30668.858% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 67210.943% |
| Alumis Inc. Common Stock | -1.28 Million USD | 13950.779% |
| Equillium, Inc. | 35.95 Million USD | -394.588% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 10518.512% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -35420.563% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 4302083.551% |
| Dominari Holdings Inc. | 2.03 Million USD | -8622.119% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 97033.03% |
| vTv Therapeutics Inc. | -13.59 Million USD | 1408.157% |
| Bio-Techne Corporation | 773.07 Million USD | 76.995% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -926.872% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 61.404% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 15313.345% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 841.635% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -1420.424% |
| Nkarta, Inc. | -5.86 Million USD | 3130.227% |
| BioCardia, Inc. | -7.24 Million USD | 2553.359% |
| Iterum Therapeutics plc | -1.75 Million USD | 10262.514% |